Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 17,973Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 17ELI LILLY AND CO

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ABEMACICLIB

US Patent Number : 7855211

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208716

Patent Use Code : U-2135

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-09-28

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ABEMACICLIB

US Patent Number : 7855211

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208716

Patent Use Code : U-1981

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-09-28

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ABEMACICLIB

US Patent Number : 7855211

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208716

Patent Use Code : U-2135

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-09-28

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ABEMACICLIB

US Patent Number : 7855211

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208716

Patent Use Code : U-2135

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-09-28

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ABEMACICLIB

US Patent Number : 7855211

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208716

Patent Use Code : U-2135

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-09-28

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ABEMACICLIB

US Patent Number : 7855211

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208716

Patent Use Code : U-3546

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-09-28

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ABEMACICLIB

US Patent Number : 7855211

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208716

Patent Use Code : U-3546

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-09-28

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ABEMACICLIB

US Patent Number : 7855211

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208716

Patent Use Code : U-3546

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-09-28

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ABEMACICLIB

US Patent Number : 7855211

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208716

Patent Use Code : U-3265

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-09-28

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ABEMACICLIB

US Patent Number : 7855211

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 208716

Patent Use Code : U-3265

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-09-28

blank